RU2010129295A - MEDICINAL PRODUCT FOR TREATING PROSTATE DISEASES AND METHOD FOR TREATING PROSTATE DISEASES - Google Patents
MEDICINAL PRODUCT FOR TREATING PROSTATE DISEASES AND METHOD FOR TREATING PROSTATE DISEASES Download PDFInfo
- Publication number
- RU2010129295A RU2010129295A RU2010129295/15A RU2010129295A RU2010129295A RU 2010129295 A RU2010129295 A RU 2010129295A RU 2010129295/15 A RU2010129295/15 A RU 2010129295/15A RU 2010129295 A RU2010129295 A RU 2010129295A RU 2010129295 A RU2010129295 A RU 2010129295A
- Authority
- RU
- Russia
- Prior art keywords
- antibodies
- activated
- aqueous
- prostate
- potentiated
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
1. Лекарственное средство для лечения заболеваний предстательной железы, содержащее активированную-потенцированную форму антител к простатоспецифическому антигену, отличающееся тем, что выполнено в виде фармацевтической композиции и содержит в качестве дополнительного усиливающего компонента активированную-потенцированную форму антител к эндотелиальной NO-синтазе. ! 2. Лекарственное средство по п.1, отличающееся тем, что активированную-потенцированную форму антител к простатоспецифическому антигену и активированную-потенцированную форму антител к эндотелиальной NO-синтазе используют в виде активированного-потенцированного водного или водно-спиртового раствора, полученного в процессе последовательного многократного разведения матричного раствора соответствующих антител в водном или водно-спиртовом растворителе и промежуточного внешнего механического воздействия - вертикального встряхивания. ! 3. Лекарственное средство по п.1 или 2, отличающееся тем, что фармацевтическая композиция выполнена в твердой лекарственной форме и содержит эффективное количество гранул нейтрального носителя, насыщенного смесью активированной-потенцированной формы антител к простатоспецифическому антигену и активированной-потенцированной формы антител к эндотелиальной NO-синтазе, и фармацевтически приемлемые добавки. !4. Лекарственное средство по п.1 или 2, отличающееся тем, что водные или водно-спиртовые растворы гомеопатически активированных-потенцированных форм антител к простатоспецифическому антигену и к эндотелиальной NO-синтазе получены путем многократного последовательного разведения и промежуточного вн 1. A drug for the treatment of prostate diseases, containing an activated-potentiated form of antibodies to a prostate-specific antigen, characterized in that it is made in the form of a pharmaceutical composition and contains, as an additional reinforcing component, an activated-potentiated form of antibodies to endothelial NO synthase. ! 2. The drug according to claim 1, characterized in that the activated-potentiated form of antibodies to the prostate-specific antigen and the activated-potentiated form of antibodies to endothelial NO synthase are used in the form of an activated-potentiated aqueous or aqueous-alcoholic solution obtained in a multiple sequential process dilution of the matrix solution of the corresponding antibodies in an aqueous or aqueous-alcoholic solvent and an intermediate external mechanical action - vertical shaking. ! 3. The drug according to claim 1 or 2, characterized in that the pharmaceutical composition is made in solid dosage form and contains an effective amount of granules of a neutral carrier saturated with a mixture of an activated-potentiated form of antibodies to a prostate-specific antigen and an activated-potentiated form of antibodies to endothelial NO- synthase, and pharmaceutically acceptable additives. !four. The drug according to claim 1 or 2, characterized in that the aqueous or aqueous-alcoholic solutions of homeopathically activated-potentiated forms of antibodies to the prostate-specific antigen and to endothelial NO synthase are obtained by repeated serial dilution and intermediate
Claims (9)
Priority Applications (53)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2010129295/15A RU2531049C2 (en) | 2010-07-15 | 2010-07-15 | Therapeutic agent for treating prostatic diseases and method of treating prostatic diseases |
KR1020137003861A KR20140014059A (en) | 2010-07-15 | 2011-07-15 | A method of increasing the effect of an activated-potentiated form of an antibody |
SE1350184A SE1350184A1 (en) | 2010-07-15 | 2011-07-15 | PROCEDURE TO INCREASE THE EFFECT OF AN ACTIVATED, POTENTIZED FORM OF AN ANTIBODY |
US13/135,898 US20130064860A1 (en) | 2010-07-15 | 2011-07-15 | Combination pharmaceutical composition and methods of theating genitourinary system disorders |
DE112011102358T DE112011102358T5 (en) | 2010-07-15 | 2011-07-15 | A method of increasing the effect of an activated-potentiated form of an antibody |
AU2011278042A AU2011278042B2 (en) | 2010-07-15 | 2011-07-15 | Combination pharmaceutical composition and methods of treating genitourinary system disorders |
MYPI2013000108A MY165267A (en) | 2010-07-15 | 2011-07-15 | Combination pharmaceutical composition and methods of treating genitourinary system disorders |
EA201300126A EA030566B1 (en) | 2010-07-15 | 2011-07-15 | Method of increasing therapeutic effectiveness of an activated-potentiated form of an antibody to an endogenous biological molecule and pharmaceutical composition |
MX2013000547A MX354187B (en) | 2010-07-15 | 2011-07-15 | Combination pharmaceutical composition and methods of treating genitourinary system disorders. |
ES201390006A ES2440393R1 (en) | 2010-07-15 | 2011-07-15 | A METHOD FOR INCREASING THE EFFECT OF A POTENTIATED ACTIVATED FORM OF AN ANTIBODY |
SG2013002324A SG187038A1 (en) | 2010-07-15 | 2011-07-15 | A method of increasing the effect of an activated-potentiated form of an antibody |
DE112011102350T DE112011102350T5 (en) | 2010-07-15 | 2011-07-15 | A combination pharmaceutical composition and method for treating disorders of the genitourinary system |
PE2013000076A PE20130398A1 (en) | 2010-07-15 | 2011-07-15 | A METHOD TO INCREASE THE EFFECT OF AN ACTIVE ENHANCED FORM OF AN ANTIBODY |
NZ606767A NZ606767A (en) | 2010-07-15 | 2011-07-15 | A method of increasing the effect of an activated-potentiated form of an antibody |
CN2011800443324A CN103108657A (en) | 2010-07-15 | 2011-07-15 | A method of increasing the effect of an activated-potentiated form of an antibody |
NZ606775A NZ606775A (en) | 2010-07-15 | 2011-07-15 | Combination pharmaceutical composition and methods of treating genitourinary system disorders |
AU2011278038A AU2011278038B2 (en) | 2010-07-15 | 2011-07-15 | A method of increasing the effect of an activated-potentiated form of an antibody |
EP11775838.3A EP2593140A2 (en) | 2010-07-15 | 2011-07-15 | A method of increasing the effect of an activated-potentiated form of an antibody |
EA201300129A EA029860B1 (en) | 2010-07-15 | 2011-07-15 | Pharmaceutical composition and methods of treating genitourinary system disorders |
EEP201300006A EE201300006A (en) | 2010-07-15 | 2011-07-15 | A pharmaceutical composition for enhancing the effect of an activated and potentiated form of an antibody |
SG10201505564VA SG10201505564VA (en) | 2010-07-15 | 2011-07-15 | Combination pharmaceutical composition and methods of treating genitourinary system disorders |
CZ20130105A CZ2013105A3 (en) | 2010-07-15 | 2011-07-15 | Method of increasing effect of antibody activated potentiated form |
IT000631A ITTO20110631A1 (en) | 2010-07-15 | 2011-07-15 | PHARMACEUTICAL COMPOSITION OF COMBINATION AND METHODS TO TREAT GENITOURINARY SYSTEM DISEASES |
SG2013002308A SG187036A1 (en) | 2010-07-15 | 2011-07-15 | Combination pharmaceutical composition and methods of treating genitourinary system disorders |
PCT/IB2011/002350 WO2012007845A2 (en) | 2010-07-15 | 2011-07-15 | A method of increasing the effect of an activated-potentiated form of an antibody |
SG10201505561TA SG10201505561TA (en) | 2010-07-15 | 2011-07-15 | A Method Of Increasing The Effect Of An Activated-Potentiated Form Of An Antibody |
JP2013519179A JP2013538791A (en) | 2010-07-15 | 2011-07-15 | Combination pharmaceutical composition and method for treating genitourinary disorders |
MX2013000543A MX2013000543A (en) | 2010-07-15 | 2011-07-15 | Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract. |
CA2804966A CA2804966A1 (en) | 2010-07-15 | 2011-07-15 | A method of increasing the effect of an activated-potentiated form of an antibody |
PCT/IB2011/002417 WO2012007849A2 (en) | 2010-07-15 | 2011-07-15 | Combination pharmaceutical composition and methods of treating genitourinary system disorders |
FR1156482A FR2962656A1 (en) | 2010-07-15 | 2011-07-15 | METHOD FOR INCREASING THE EFFECT OF AN ACTIVATED-POTENTIALIZED FORM OF ANTIBODY |
GB1302649.7A GB2495884B (en) | 2010-07-15 | 2011-07-15 | A method of increasing the effect of an activated-potentiated form of an antibody |
US13/135,901 US9308275B2 (en) | 2010-07-15 | 2011-07-15 | Method of increasing the effect of an activated-potentiated form of an antibody |
FR1156476A FR2962655A1 (en) | 2010-07-15 | 2011-07-15 | PHARMACEUTICAL ASSOCIATION COMPOSITION AND USES THEREOF IN METHODS OF TREATMENT OF GENITAL URINARY SYSTEM DISORDERS |
IT000639A ITTO20110639A1 (en) | 2010-07-15 | 2011-07-15 | METHOD TO INCREASE THE EFFECT OF AN ACTIVE-ENHANCED SHAPE OF AN ANTI-BODY |
CN201180044500XA CN103282384A (en) | 2010-07-15 | 2011-07-15 | Combination pharmaceutical composition and methods of treating genitourinary system disorders |
GB1302651.3A GB2495885B (en) | 2010-07-15 | 2011-07-15 | Combination pharmaceutical composition and methods of treating genitourinary system disorders |
JP2013519175A JP2013538186A (en) | 2010-07-15 | 2011-07-15 | Method for increasing the effect of activation-enhancing antibodies |
EP11784771.5A EP2593483A2 (en) | 2010-07-15 | 2011-07-15 | Combination pharmaceutical composition and methods of treating genitourinary system disorders |
BR112013000840A BR112013000840A2 (en) | 2010-07-15 | 2011-07-15 | method for enhancing the effect of potentiated activated form of antibody to biological endogenous molecule, pharmaceutical composition and use of combination of endogenous biological molecule with potentiated activated form of antibody to endothelial synthase. |
ES201390004A ES2425314R1 (en) | 2010-07-15 | 2011-07-15 | Combined pharmaceutical composition and use to prepare medicines for the treatment of disorders of the genitourinary system |
CA2805094A CA2805094A1 (en) | 2010-07-15 | 2011-07-15 | Combination pharmaceutical composition and methods of treating genitourinary system disorders |
ARP110102578A AR082247A1 (en) | 2010-07-15 | 2011-07-18 | A METHOD FOR INCREASING THE EFFECTS OF A POTENTIATED ACTIVATED FORM OF AN ANTIBODY |
CL2013000099A CL2013000099A1 (en) | 2010-07-15 | 2013-01-10 | A method of increasing the effect of an potentiated active form of an antibody to an endogenous biological molecule, comprising the combination of the endogenous biological molecule with an enhanced active form of an endoltelial non-synthase antibody; composition that understands it. |
NO20130222A NO20130222A1 (en) | 2010-07-15 | 2013-02-08 | Process for increasing the effect of an activated-potentiated form of an antibody |
LT2013016A LT5988B (en) | 2010-07-15 | 2013-02-14 | A method of increasing the effect of an activated-potentiated form of an antibody |
DKPA201370079A DK201370079A (en) | 2010-07-15 | 2013-02-14 | A method of increasing the effect of an activated-potentiated form of an antibody |
FI20135143A FI20135143L (en) | 2010-07-15 | 2013-02-15 | A method of increasing the potency of an activated potentiated form of an antibody |
US15/060,202 US20160251448A1 (en) | 2010-07-15 | 2016-03-03 | Method of increasing the effect of an activated-potentiated form of an antibody |
US15/060,157 US20160244531A1 (en) | 2010-07-15 | 2016-03-03 | Method of increasing the effect of an activated-potentiated form of an antibody |
JP2016131664A JP2016199570A (en) | 2010-07-15 | 2016-07-01 | Combination pharmaceutical composition and methods of treating genitourinary system disorders |
JP2016135750A JP2016216483A (en) | 2010-07-15 | 2016-07-08 | Method of increasing effect of activated-potentiated antibody |
JP2018085388A JP2018150322A (en) | 2010-07-15 | 2018-04-26 | Combined pharmaceutical composition, and method for treating urogenital system disorder |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2010129295/15A RU2531049C2 (en) | 2010-07-15 | 2010-07-15 | Therapeutic agent for treating prostatic diseases and method of treating prostatic diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2010129295A true RU2010129295A (en) | 2012-01-20 |
RU2531049C2 RU2531049C2 (en) | 2014-10-20 |
Family
ID=45785351
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2010129295/15A RU2531049C2 (en) | 2010-07-15 | 2010-07-15 | Therapeutic agent for treating prostatic diseases and method of treating prostatic diseases |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2531049C2 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997005901A1 (en) * | 1995-08-03 | 1997-02-20 | Sinha Akhouri A | Targeting of organs by immunoconjugates |
RU2192889C1 (en) * | 2001-03-16 | 2002-11-20 | Эпштейн Олег Ильич | Medicinal preparation and method for treating prostatic diseases |
-
2010
- 2010-07-15 RU RU2010129295/15A patent/RU2531049C2/en active
Also Published As
Publication number | Publication date |
---|---|
RU2531049C2 (en) | 2014-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2011127052A (en) | METHOD FOR TREATING THE HEAD-VARIABLE OF VARIOUS GENESIS, KINETOSIS AND VEGETOVASCULAR DYSTONIA (OPTIONS) AND MEDICINAL PRODUCT | |
RU2011127059A (en) | NEUROTROPIC MEDICINE AND METHOD OF TREATMENT OF ORGANIC DISEASES OF THE NERVOUS SYSTEM, PSYCHOORGANIC SYNDROME AND ENCEPHALOPATHY OF VARIOUS GENESIS | |
RU2010133053A (en) | INTEGRATED MEDICINE FOR TREATMENT OF VIRAL DISEASES AND METHOD OF TREATMENT OF VIRAL DISEASES | |
RU2010129295A (en) | MEDICINAL PRODUCT FOR TREATING PROSTATE DISEASES AND METHOD FOR TREATING PROSTATE DISEASES | |
RU2011127058A (en) | MEDICINE FOR TREATMENT OF ALZHEIMER'S DISEASE AND METHOD OF TREATMENT OF ALZHEIMER'S DISEASE | |
RU2010130353A (en) | MEDICINE FOR TREATMENT OF ALZHEIMER'S DISEASE AND METHOD OF TREATMENT OF ALZHEIMER'S DISEASE | |
RU2010129294A (en) | MEDICINE FOR TREATMENT OF ERECTILE DYSFUNCTIONS AND METHOD OF TREATMENT OF ERECTILE DYSFUNCTIONS | |
RU2010130358A (en) | MEDICINE FOR TREATMENT OF ATTENTION DEFICIENCY SYNDROME AND METHOD FOR TREATMENT OF ATTENTION DEFICIENCY SYNDROME | |
RU2010130355A (en) | MEDICINAL PRODUCT AND METHOD FOR TREATMENT OF ORGANIC DISEASES OF THE NERVOUS SYSTEM, PSYCHOORGANIC SYNDROME AND ENCEPHALOPATHY OF VARIOUS GENESIS | |
RU2010130356A (en) | MEDICINAL PRODUCT AND METHOD FOR TREATMENT OF VEGETO-VASCULAR DYSTONIA, VERTAIN SYNDROME OF VARIOUS GENESIS AND KINETOSIS | |
RU2011134414A (en) | FULVIC ACID COMBINATION FOR TREATMENT OF VARIOUS CONDITIONS AND DISEASES | |
RU2011127055A (en) | MEDICINAL PRODUCT FOR TREATMENT OF NEUROLOGICAL-BEHAVIORAL DEVELOPMENT DISORDERS AND METHOD OF TREATMENT OF NEUROLOGICAL-BEHAVIORAL DISORDERS OF DEVELOPMENT | |
RU2010130350A (en) | METHOD FOR TREATING DEPENDENCE ON PSYCHOACTIVE SUBSTANCES, ALCOHOLISM AND TOBACCO SMOKING AND MEDICINAL PRODUCT FOR TREATING DEPENDENCE ON PSYCHOACTIVE SUBSTANCES, ALCOHOLISM AND TOBACCO SMOKING | |
RU2011124809A (en) | MEDICINE FOR TREATMENT OF PATHOLOGICAL SYNDROME AND METHOD FOR TREATING FUNCTIONAL INTESTINAL DISORDERS | |
RU2013154072A (en) | MEDICINE FOR TREATMENT OF KINETOSIS AND METHOD OF TREATMENT OF KINETOSIS | |
RU2010131387A (en) | MEDICINE FOR TREATMENT OF MULTIPLE SCLEROSIS AND METHOD OF TREATMENT OF MULTIPLE SCLEROSIS | |
RU2013154073A (en) | PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING A PATHOLOGICAL SYNDROME | |
RU2013154070A (en) | METHOD FOR TREATMENT OF VEGETAIN-VASCULAR DISTONIA AND MEDICINAL PRODUCT | |
RU2013152871A (en) | DIABETES TREATMENT METHOD AND COMBINED MEDICINE | |
RU2010129293A (en) | MEDICINE FOR TREATMENT OF FUNCTIONAL DISORDERS OF THE GASTROINTESTINAL TRACT AND METHOD OF TREATMENT OF FUNCTIONAL DISORDERS OF THE GASTROINTESTINAL TRACT | |
RU2011127056A (en) | MEDICINAL PRODUCT FOR TREATMENT OF PATHOLOGICAL SYNDROME AND METHOD FOR TREATING MULTIPLE SCLEROSIS | |
RU2013154071A (en) | MEDICINAL PRODUCT AND METHOD FOR TREATMENT OF HEAD-WAYS | |
RU2010131386A (en) | MEDICINAL PRODUCT FOR TREATMENT OF INFECTIOUS DISEASES ASSOCIATED WITH NEUROTOXIC DISORDERS, AND METHOD FOR TREATMENT OF INFECTIOUS DISEASES ASSOCIATED WITH NEUROTOXIC DISEASES | |
RU2010129297A (en) | MEDICINAL PRODUCT FOR TREATMENT OF INFECTIOUS DISEASES ASSOCIATED WITH NEUROTOXIC DISORDERS, AND METHOD FOR TREATMENT OF INFECTIOUS DISEASES ASSOCIATED WITH NEUROTOXIC DISEASES | |
RU2010129292A (en) | METHOD FOR TREATING VEGETAIN VASCULAR DISTONIA AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF VEGETAIN VASCULAR DISTONIA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HZ9A | Changing address for correspondence with an applicant | ||
QZ41 | Official registration of changes to a registered agreement (patent) |
Free format text: LICENCE FORMERLY AGREED ON 20130114 Effective date: 20160229 |
|
QZ41 | Official registration of changes to a registered agreement (patent) |
Free format text: LICENCE FORMERLY AGREED ON 20130114 Effective date: 20170830 |
|
QC41 | Official registration of the termination of the licence agreement or other agreements on the disposal of an exclusive right |
Free format text: LICENCE FORMERLY AGREED ON 20130114 Effective date: 20190129 |
|
PC41 | Official registration of the transfer of exclusive right |
Effective date: 20190201 |